Navigation Links
United BioSource Corporation and CogState Ltd. Form Strategic Partnership to Support Cognitive Assessment in Clinical Research
Date:8/5/2008

UBC Makes Strategic Investment in CogState Ltd. to Support Partnership Comprehensive service will standardize administration, measurement and

global implementation of cognitive testing in clinical trials

BETHESDA, Md., Aug. 5 /PRNewswire/ --

Key points:

-- United BioSource Corporation (UBC) and CogState Ltd. enter into a strategic partnership to facilitate the use of cognitive testing in clinical trials.

-- UBC has made a direct investment in CogState to support current and anticipated growth.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070910/NEM007LOGO )

United BioSource Corporation (UBC) today announces that on July 28, 2008, it entered into a strategic partnership with CogState Ltd. to increase the ability for pharmaceutical and life sciences companies to conduct cognitive testing in clinical trials. Customers will be able to leverage both companies' scientific resources, software capabilities and global operations to support full-scale clinical development programs.

Cognitive impairment is a defining aspect of many psychiatric and neurological diseases, including Alzheimer's disease, schizophrenia, Parkinson's disease, ADHD, depression and stroke. Consequently, improving cognition has become an important outcome for new treatment strategies in these conditions and there is a need for sensitive measures, assays and analyses that can be used to guide decisions about cognition. Furthermore there is also a need for systems that can be used to cost-effectively manage the use of cognitive assessments in multi-national clinical trials.

Within this context, UBC and CogState have partnered to advance the field of cognitive assessment in clinical trials through provision of an integrated cognitive testing solution for use in Phase I through IV clinical trials internationally. The comprehensive cognitive service sol
'/>"/>

SOURCE United BioSource Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. United Therapeutics Reports Second Quarter 2008 Financial Results
2. Silence Therapeutics Receives Allowance from United States Patent and Trademark Office for its Core RNAi Patent
3. Mylan Launches First Generic Version of Antihypertensive Sular(R) ER in the United States
4. United Therapeutics to Announce Second Quarter 2008 Financial Results Before Market Open on Thursday, July 31, 2008
5. Animetrics Inc. Selected to Provide 3D Face Viewer Technology for United States Army Biometric Automated Toolset (BAT)
6. Warburg Pincus Acquires 5.4% of WuXi PharmaTechs Outstanding Ordinary Shares from United Overseas Bank
7. Genzyme Files Applications for Approval of Mozobil in the United States and Europe
8. Sturgeon and Caviar From Aquaculture: United Food Technologies AG Hands Over Turnkey Plant
9. United Therapeutics Announces the Results of Its 2008 Annual Meeting of Shareholders
10. United Therapeutics Reports First Quarter 2008 Financial Results
11. United Therapeutics to Announce First Quarter 2008 Financial Results Before Market Open on Thursday, May 1, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)...  Neogen Corporation (NASDAQ: NEOG ) announced today ... plan in accordance with Securities and Exchange Commission rule ... Neogen Corporation, is a minority owner of this entity ... Herbert does not have control of this entity, ... only for a portion of the shares owned by ...
(Date:3/27/2015)... 27, 2015  CASI Pharmaceuticals, Inc. (Nasdaq: CASI ... and commercialization of innovative therapeutics addressing cancer and other ... commercial focus on China , today ... ended December 31, 2014.  The Company ... per share, for the three months ended December 31, ...
(Date:3/26/2015)... March 26, 2015 The Market Element ... a strategic alliance with Designing Gig LLC to provide ... , “Forging this alliance with Designing Gig ... we can extend a comprehensive, end-to-end, digital solution for ... and execution,” said Chuck Miller, president of The Market ...
(Date:3/26/2015)... March 26, 2015 ReliantHeart, Inc., an ... Transonic, a supplier of precision transit-time flow measurement solutions, ... greatly improve the efficiency of the HeartAssist5® ... patients to experience greater mobility and peace of mind. ... miniature flow board, will draw 1/6th of the power ...
Breaking Biology Technology:Neogen CEO adopts 10b5-1 Trading Plan 2CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 2CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 3CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 4CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 5CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 6The Market Element LLC and Designing Gig LLC Form Strategic Alliance 2LVAD patients to have greater mobility and peace of mind through Transonic and ReliantHeart’s True Flow collaboration for the HeartAssist5® 2LVAD patients to have greater mobility and peace of mind through Transonic and ReliantHeart’s True Flow collaboration for the HeartAssist5® 3
... designed to help consulting engineers and other ... GROVE, Ill., April 8 Siemens Building ... Science Solutions Design Guide written expressly for ... looking to design and specify effective and ...
... Kiadis,Pharma reported preliminary clinical data on ATIR(TM) ... Data was presented by the,company,s principal investigator ... Symposium at the Annual European Bone Marrow ... March 30, 2009. Only the 6,highest ranked ...
... Micromet, Inc. (Nasdaq: MITI ), a ... treatment of cancer, inflammation and autoimmune diseases, today ... Journal of Immunotherapy (1) demonstrating the potent anti-tumor ... antigen (CEA) and to CD3 on T cells. ...
Cached Biology Technology:Siemens Offers Life Science Solutions Design Guide for Consulting Engineers 2Kiadis Pharma Reports ATIR(TM) Clinical Data, Further Supporting its Potential in Mismatched Bone Marrow Transplantations 2Pre-Clinical Data on CEA-specific BiTE Antibody Published in Journal of Immunotherapy Demonstrate Potent Control of Tumor Growth 2Pre-Clinical Data on CEA-specific BiTE Antibody Published in Journal of Immunotherapy Demonstrate Potent Control of Tumor Growth 3Pre-Clinical Data on CEA-specific BiTE Antibody Published in Journal of Immunotherapy Demonstrate Potent Control of Tumor Growth 4
(Date:3/17/2015)...  MecklerMedia Corporation (OTCQX: MECK) announced its ... ever held in New York City ... 2015 at the Javits Convention Center. ... Acorn Product Development; Axis NJ; c-Link Systems; CoroWare; ... NewBotic Corporation; Neya Systems LLC; Reliabotics; RoboKind; RocketFarm ...
(Date:3/12/2015)... MOUNTAIN VIEW, Calif. , March 12, 2015 ... EDTLOCATION:Online, with Complimentary Registration here: http://bit.ly/1G7Os0L . ... Program Manager Aravind SeshagiriPhoto - http://photos.prnewswire.com/prnh/20150311/181111 ... future in order to compete in several different ... the market is currently witnessing an uptrend. ...
(Date:3/10/2015)... --  Tute Genomics , pioneer in affordable, accurate and ... company PrimBio Research Institute to be its ... interpretation. PrimBio, a certified Life Technologies Ampliseq ... to support the work of experts on the front ... of exome sequencing services: 1) Targeted Exome and 2) ...
Breaking Biology News(10 mins):MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 2Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 3PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis 2PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis 3
... about selective serotonin reuptake inhibitors (SSRIs) suggests that these ... like depression and anxiety, have multiple effects on our ... 2010 issue of GENETICS ( http://www.genetics.org ), ... or pathways affected by SSRIs. Such secondary pathways could ...
... at the Buck Institute for Age Research have successfully ... rodents afflicted with Parkinson,s Disease (PD). The research, ... had previously developed, can be used to manufacture the ... paves the way for the use of iPSC,s in ...
... is now clear that RNA plays a major role in ... while also serving as an important tool in functional genomics. ... Review series is providing RNA experts and researchers not only ... also a framework to generate new insights and applications. ...
Cached Biology News:SSRIs may pack more punch at the cellular level than believed 2Scientists successfully use human induced pluripotent stem cells to treat Parkinson's in rodents 2
... is used for single-color real-time detection using ... JOE fluorophores and features a real-time PCR ... from 96 wells, a gene expression macro ... The system includes the optical module and ...
... , CapSure HS and CapSure Macro LCM ... of populations of pure cells from tissue ... Microdissection., Ensure the Integrity of Microdissected ... CapSure LCM Caps have a patented transfer ...
... new MyiQ real-time PCR detection system offers ... common green fluorescent dyes such as FAM ... directly with the iCycler thermal cycler, offering ... Peltier-effect driven performance. The MyiQ real-time PCR ...
Opticon continuous fluorescence detector; includes optical base, analysis software, computer and monitor (this is an accessory for the DNA Engine thermal cyclers which must be ordered seperately)...
Biology Products: